Evidence map›Paper›PMID 41993881›Full record

ArticleComputational and structural biotechnology journal2026

The State of Peptide Detectability in Computational Proteomics and Guidelines for AI Applications.

Vincent Schilling, Aleksandar Anžel, Joerg Doellinger, Peter Lasch, Dominik Heider, Georges Hattab

Abstract read
In one paragraph

Article in Computational and structural biotechnology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vincent SchillingRobert-Koch Institute, Center for Artificial Intelligence in Public Health Research (ZKI-PH), Berlin 13353, Germany.ORCID https://orcid.org/0009-0001-6992-4805
Aleksandar AnželRobert-Koch Institute, Center for Artificial Intelligence in Public Health Research (ZKI-PH), Berlin 13353, Germany.ORCID https://orcid.org/0000-0002-0678-2870
Joerg DoellingerRobert-Koch Institute, Center for Biological Threats and Special Pathogens: Proteomics and Spectroscopy (ZBS 6), Berlin 13353, Germany.ORCID https://orcid.org/0000-0001-8309-082X
Peter LaschRobert-Koch Institute, Center for Biological Threats and Special Pathogens: Proteomics and Spectroscopy (ZBS 6), Berlin 13353, Germany.
Dominik HeiderInstitute of Medical Informatics, University of Münster, Münster 48149, Germany.ORCID https://orcid.org/0000-0002-3108-8311
Georges HattabRobert-Koch Institute, Center for Artificial Intelligence in Public Health Research (ZKI-PH), Berlin 13353, Germany.ORCID https://orcid.org/0000-0003-4168-8254

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Artificial intelligence (AI) techniques have transformed proteomics and computational biology over the past decade, particularly in mass spectrometry tasks such as fragment spectra prediction, retention time prediction, and peptide detectability prediction. However, as the volume of proteomics data grows, the need for robust, reproducible, and comparable AI applications has become increasingly urgent. Here, we present a comprehensive scoping review of AI techniques for peptide detectability, an essential and rapidly evolving problem in computational proteomics. By analyzing more than 25 peer-reviewed methods published between 2006 and 2025, we identify a persistent discrepancy between increasing algorithmic sophistication and consistent adherence to established machine learning standards. Current studies frequently exhibit heterogeneity in dataset construction, limited transparency in model design and evaluation, and restricted reproducibility. To address these challenges, we propose actionable guidelines focused on transparent technical reporting, rigorous dataset separation, comprehensive performance evaluation, and reproducibility. Encouragingly, recent tools demonstrate that such standards can be met in practice. Furthermore, we outline a future research agenda that emphasizes the integration of structural biology frameworks, the transition toward data-independent acquisition datasets, and the development of explainable AI to ensure models are both biologically interpretable and transferable across evolving instrument platforms. While centered on peptide detectability, these principles offer valuable insights and can inform future work across a wide range of computational proteomics applications.

Identifiers

PMID41993881
PMCPMC13082577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.